Skip to main content

Identification of Efflux-Mediated Multi-drug Resistance in Bacterial Clinical Isolates by Two Simple Methods

  • Protocol
  • First Online:
Book cover Antibiotic Resistance Protocols

Part of the book series: Methods in Molecular Biology ((MIMB,volume 642))

Abstract

Two simple, instrument-free, user-friendly methods that can readily be implemented by a routine microbiology laboratory are described for the detection of multi-drug-resistant (MDR) isolates that overexpress efflux pump (EP) systems responsible for the MDR phenotype. The first method employs the universal EP substrate ethidium bromide (EB) at varying concentrations in agar-containing plates upon which the contents of an overnight culture are swabbed as spokes of a wheel. In this method, named the EB–agar cartwheel method, it is assumed that the smallest concentration of EB that produces fluorescence of the bacterial mass represents the highest concentration of EB that the bacteria can exclude. Consequently, as the efflux system(s) of a given MDR clinical bacterial isolate is overexpressed relative to that of a reference strain, the minimal concentration of EB producing fluorescence is significantly greater. A simple formula is provided which affords the ranking of MDR clinical isolates with respect to the degree of their efflux capacity. The second method, which can be used after the first one, determines whether the MDR phenotype is based upon an overexpressed efflux system. This method employs a 24-well microplate with separate wells containing or lacking an efflux pump inhibitor (EPI) and Kirby–Bauer discs that correspond to the antibiotics to which the MDR strain is resistant. After the wells are inoculated with the MDR clinical isolate, the plate is incubated overnight and each well is evaluated by eye for evidence of growth. Comparison of growth to the relevant control enables the observer to determine the following outcomes: no growth produced by the EPI–antibiotic combination (i.e., reversal of antibiotic resistance); reduced growth produced by the EPI–antibiotic combination; no difference in growth, i.e., EPI does not affect the resistance to the given antibiotic. If the first method showed that there was a significant difference between the minimum concentrations of EB in agar that produced fluorescence for the clinical isolate and its reference strain, then one can conclude that if the EPI had no effect on reducing antibiotic resistance, the differences in the EB concentrations that produced fluorescence are probably due to differences in the permeability of the strain to EB, reflecting a downregulation of porins if the clinical isolate is a Gram-negative bacterium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nikaido H (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656

    Article  CAS  PubMed  Google Scholar 

  2. Zgurskaya HI, Nikaido H (2000) Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol 37:219–225

    Article  CAS  PubMed  Google Scholar 

  3. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M et al (2007) Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE 2:e365

    Article  PubMed  Google Scholar 

  4. Poole K (2007) Efflux pumps as antimicrobial resistance mechanisms. Ann Med 39:162–176

    Article  CAS  PubMed  Google Scholar 

  5. Van Bambeke F, Pagès JM, Lee VJ (2006) Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Patents Anti-Infect Drug Disc 1:157–175

    Article  Google Scholar 

  6. Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382–402

    Article  CAS  PubMed  Google Scholar 

  7. Piddock LJ (2006) Multidrug-resistance efflux pumps – not just for resistance. Nat Rev Microbiol 4:629–636

    Article  CAS  PubMed  Google Scholar 

  8. Li XZ, Nikaido H (2004) Efflux-mediated drug resistance in bacteria. Drugs 64:159–204

    Article  CAS  PubMed  Google Scholar 

  9. Li XZ, Zhang L, Nikaido H (2004) Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother 48:2415–2423

    Article  CAS  PubMed  Google Scholar 

  10. Nikaido H, Zgurskaya HI (1999) Antibiotic efflux mechanisms. Curr Opin Infect Dis 12:529–536

    CAS  PubMed  Google Scholar 

  11. Lomovskaya O, Bostian KA (2006) Practical applications and feasibility of efflux pump inhibitors in the clinic–a vision for applied use. Biochem Pharmacol 71:910–918

    Article  CAS  PubMed  Google Scholar 

  12. Lomovskaya O, Watkins WJ (2001) Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8:1699–1711

    CAS  PubMed  Google Scholar 

  13. Marquez B (2005) Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87:1137–1147

    Article  CAS  PubMed  Google Scholar 

  14. Khan SZ, Longland CL, Michelangeli F (2000) The effects of phenothiazines and other calmodulin antagonists on the sarcoplasmic and endoplasmic reticulum Ca(2+) pumps. Biochem Pharmacol 60:1797–1806

    Article  CAS  PubMed  Google Scholar 

  15. Amaral L, Martins M, Viveiros M (2007) Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 59:1237–1246

    Article  CAS  PubMed  Google Scholar 

  16. Clausen T (2003) Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83:1269–1324

    CAS  PubMed  Google Scholar 

  17. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K (2000) Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A 97:1433–1437

    Article  CAS  PubMed  Google Scholar 

  18. Kaatz GW, Moudgal VV, Seo SM (2002) Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. J Antimicrob Chemother 50:833–838

    Article  CAS  PubMed  Google Scholar 

  19. Nakajima Y (1999) Mechanisms of bacterial resistance to macrolide antibiotics. J Infect Chemother 5:61–74

    Article  CAS  PubMed  Google Scholar 

  20. Baquero F (2001) Low-level antibacterial resistance: a gateway to clinical resistance. Drug Resist Updat 4:93–105

    Article  CAS  PubMed  Google Scholar 

  21. Joux F, Lebaron P (2000) Use of fluorescent probes to assess physiological functions of bacteria at single-cell level. Microb Infect 2:1523–1535

    Article  CAS  Google Scholar 

  22. Jernaes MW, Steen HB (1994) Staining of Escherichia coli for flow cytometry: influx and efflux of Ethidium bromide. Cytometry 17:302–309

    Article  CAS  Google Scholar 

  23. Mortimer PG, Piddock LJ (1991) A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 28:639–653

    Article  CAS  PubMed  Google Scholar 

  24. Duffy L, Dykes GA (2006) Growth temperature of four Campylobacter jejuni strains influences their subsequent survival in food and water. Lett Appl Microbiol 43:596–601

    Article  CAS  PubMed  Google Scholar 

  25. Martins M, Cardoso A, Viveiros M, Amaral L (2007) Simple method to screen inhibitors of bacterial efflux pumps. Abstract C2-2056, p.148. In: Proceedings of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, Chicago, Il, USA.

    Google Scholar 

  26. Martins M, Cardoso A, Viveiros M, Charepe N, Rodrigues L, Couto I, et al (2008) Simple methods to screen efflux pump activity and efflux pump inhibitors in multi-drug resistant Escherichia coli. Abstract P1998, p.159. In: Proceedings of the 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). European Society of Clinical Microbiology and Infectious Diseases, Barcelona, Spain.

    Google Scholar 

Download references

Acknowledgments

We thank Seamus Fanning and Jean-Marie Pagès for providing the Salmonella and Enterobacter strains, respectively. The help/participation of Gabriella Spengler, Liliana Rodrigues, Ana Martins, Ana Cardoso, Nadia Charepe, Celeste Falcão, Sofia Santos Costa, and Daniela Sampaio in the characterization of reference and clinical bacterial strains by the methods described is also acknowledged. This work was supported by grants EU-FSE/FEDER-POCI/SAU-MMO/59370/2004 and EU-FSE/FEDER-PTDC/BIA-MIC/71280/2006 provided by the Fundação para a Ciência e a Tecnologia (FCT) of Portugal. M. Martins was supported by grant SFRH/BD/14319/2003 (FCT, Portugal).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonard Amaral .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Martins, M., Couto, I., Viveiros, M., Amaral, L. (2010). Identification of Efflux-Mediated Multi-drug Resistance in Bacterial Clinical Isolates by Two Simple Methods. In: Gillespie, S., McHugh, T. (eds) Antibiotic Resistance Protocols. Methods in Molecular Biology, vol 642. Humana Press. https://doi.org/10.1007/978-1-60327-279-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-279-7_11

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-278-0

  • Online ISBN: 978-1-60327-279-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics